Windward Bio IPO Prices at $17 a Share

Windward Bio Group priced its initial public offering at $17 per share, the Basel, Switzerland-based company said, raising the sale of 10.3 million shares at the midpoint of its expected range. The company is also completing a separate $50 million private placement with Sanofi.

November 13, 2026, 03:10 AM 846 0

Windward had expected to offer 10.3 million shares for $16 to $18 each. Its largest stockholders include Novo Holdings and OrbiMed. The shares are set to trade on the Nasdaq Global Market under the symbol WWB.

Alongside the IPO, Windward sold stock and warrants to Sanofi in a private placement. In September, the company reported positive interim results from the Phase 2 portion of a clinical trial evaluating twice-yearly dosing of WIN378 in asthma.

When reusing this material a link to Money Talk is required.